Research Insights

Systematically reviewed, thoroughly assessed – for consistent understanding of the UMBRELLA strategy.

Stock Analyses on the UMBRELLA Strategy

In-depth stock analyses on selected stocks of the UMBRELLA Strategy. The assessments follow five analysis phases – from geopolitical developments and industry structures to fundamental data, market sentiment, and technical analysis.

RHM
Verteidigung

Rheinmetall

Europäische Sicherheitsarchitektur, Marktposition, Auftragsbestand und Fundamentaldaten.

UnternehmensanalyseResearch ansehen
GOOGL
Technologie & KI

Alphabet

Cloud, künstliche Intelligenz, digitales Geschäftsmodell und langfristige Wachstumstreiber.

UnternehmensanalyseResearch in Vorbereitung
MU
Halbleiter

Micron Technology

Speichertechnologie, KI-Infrastruktur, Branchenzyklen und Nachfrageentwicklung.

UnternehmensanalyseResearch in Vorbereitung
LLY
Gesundheitswesen

Eli Lilly

Pharmazeutische Innovation, Produktpipeline, Wachstumsperspektiven und Wettbewerb.

UnternehmensanalyseResearch in Vorbereitung
Alphabet Logo
Alphabet
Technology

Valuation Analysis: Alphabet

ISIN: US02079K3059

Alphabet new to the UMBRELLA Strategy: What growth, Google Cloud, AI, valuation, and technical analysis mean for the current analysis.
Active icon
More research
Eli Lilly_Logo
Eli Lilly
Healthcare

Valuation Analysis: Eli Lilly and Company

ISIN: US5324571083

Eli Lilly reported an exceptionally strong Q2 2026. Growth and higher guidance impress, but valuation, pricing pressure, and cash flow
Active icon
More research
Palantir_Logo
Palantir
Technology

Valuation Analysis: Palantir Technologies

ISIN: US69608A1088

Palantir rapidly increases revenue, margins, and cash flow. The analysis highlights AI opportunities, defense business, and valuation risks.
Active icon
More research
Revolution Medicines
Healthcare

Valuation Analysis: Revolution Medicines

ISIN: US76155X1000

Revolution Medicines develops innovative cancer therapies against RAS mutations and is one of the leading biotechnology companies in the field
Active icon
More research
JNJ Logo
Johnson
Healthcare

Valuation Analysis: Johnson & Johnson

ISIN: US4781601046

Johnson & Johnson is one of the world's leading healthcare companies. The company benefits from a strong position in pharmaceuticals
Active icon
More research